Specialty Therapies and Biosimilars Summit
January 22 - 24, 2020 - Miami FL US
CBI’s Specialty Therapies and Biosimilars Congress tackles the challenges involved in managing the cost and quality of innovative therapies that are controlling or conquering diseases that were once considered untreatable. Pharmaceutical executives, payers, PBMs, and specialty pharmacies gather for an open exchange of ideas on the latest challenges and trends. The conference includes a full track of programming on biosimilars in addition to one on specialty therapies. You choose from sessions in both tracks.
This website uses cookies to ensure you get the best experience on our website. Learn more